Aberrant hypomethylation at the gene promoter region is the mechanism that mediates the overexpression of ADAM12, leading to an association with worse tumour growth outcomes in different types of cancer, like triple-negative breast cancer (TNBC) [59] and gastric cancer (GC) [60]. Here, ADAM12 is linked to neoplasm.